During the past decade, Studien GbR Braunschweig conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Studien GbR Braunschweig" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator, "Institute of Clinical Cancer Research (IKF)" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Studien GbR Braunschweig" are "HER2-Positive Primary Breast Cancer" (1 trials), "HER2-negative Metastatic Breast Cancer" (1 trials), "Hormone Receptor-positive Metastatic Breast Cancer" (1 trials), "Ovarian Cancer" (1 trials) and "Quality of Life" (1 trials). Many other conditions were trialed in "Studien GbR Braunschweig" in a lesser frequency.

Most popular intervention types in "Studien GbR Braunschweig" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Abemaciclib + Aromatase Inhibitor" (1 trials), "Abemaciclib + Fulvestrant" (1 trials), "DS-8201a" (1 trials), "T-DM1" (1 trials) and "Trabectidin (Yondelis)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Studien GbR Braunschweig" are 2 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "Studien GbR Braunschweig". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Studien GbR Braunschweig, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Studien GbR Braunschweig, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".